Subtype distribution and molecular characterization of Blastocystis from hemodialysis patients in Turkey

ArticleAçık Erişim

Özet

Introduction: The aim of this study was to determine the Blastocystis prevalence and subtypes in hemodialysis patients in Turkey. Methodology: Eighty-four patients diagnosed with end-stage renal failure who were undergoing hemodialysis and 20 healthy volunteers were enrolled. Blastocystis presence was investigated by native-Lugol, trichrome staining, PCR using STS primers, and DNA sequencing analysis. Results: Among the stool samples from the hemodialysis patients, 9.52% (8/84) were found to be Blastocystis-positive with the native-Lugol and trichrome staining. Seven of the eight Blastocystis isolates were subtyped using STS primers. Blastocystis subtype distribution was as follows: one had ST1, two had ST2, two had ST3, two had ST3+ST6, and one was not subtyped. Blastocystis positivity was detected in two healthy control (2/20, %10), one subject had ST1, and the other was not subtyped. All subtypes identified by PCR were confirmed by the sequencing analysis. In the two samples that had mixed subtypes (ST3+ST6) when using the STS primers, only ST3 was detected in the sequencing analysis. Although some patients have multiple symptoms, the most common symptoms in Blastocystis positive patients were bloating (5/8), diarrhea (4/8), nausea and vomiting (2/8), and gas and weight loss (1/8). Also, only one patient had Giardia intestinalis. Conclusions: This was the first study to determine the Blastocystis subtypes in hemodialysis patients. A rare subtype, ST6, was identified in two of the patients. Thus, the ST6 infections were attributable to transmission from poultry infections. The presence of this unusual subtype suggests the need for further extensive studies of hemodialysis patients. Copyright © 2020 Gulhan et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13044Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3855/jidc.12650Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGulhan, Baris
dc.contributor.authorAydin, Merve
dc.contributor.authorDemirkazik, Mehtap
dc.contributor.authorKoltas, Ismail Soner
dc.contributor.authorCikman, Aytekin
dc.contributor.authorTurkmen, Kultigin
dc.contributor.authorDuran, Tugce
dc.date.accessioned2026-10-18T20:27:53.052042145Z
dc.date.available2026-10-18T20:27:53.052042145Z
dc.date.issued2020
dc.description.abstractIntroduction: The aim of this study was to determine the Blastocystis prevalence and subtypes in hemodialysis patients in Turkey. Methodology: Eighty-four patients diagnosed with end-stage renal failure who were undergoing hemodialysis and 20 healthy volunteers were enrolled. Blastocystis presence was investigated by native-Lugol, trichrome staining, PCR using STS primers, and DNA sequencing analysis. Results: Among the stool samples from the hemodialysis patients, 9.52% (8/84) were found to be Blastocystis-positive with the native-Lugol and trichrome staining. Seven of the eight Blastocystis isolates were subtyped using STS primers. Blastocystis subtype distribution was as follows: one had ST1, two had ST2, two had ST3, two had ST3+ST6, and one was not subtyped. Blastocystis positivity was detected in two healthy control (2/20, %10), one subject had ST1, and the other was not subtyped. All subtypes identified by PCR were confirmed by the sequencing analysis. In the two samples that had mixed subtypes (ST3+ST6) when using the STS primers, only ST3 was detected in the sequencing analysis. Although some patients have multiple symptoms, the most common symptoms in Blastocystis positive patients were bloating (5/8), diarrhea (4/8), nausea and vomiting (2/8), and gas and weight loss (1/8). Also, only one patient had Giardia intestinalis. Conclusions: This was the first study to determine the Blastocystis subtypes in hemodialysis patients. A rare subtype, ST6, was identified in two of the patients. Thus, the ST6 infections were attributable to transmission from poultry infections. The presence of this unusual subtype suggests the need for further extensive studies of hemodialysis patients. Copyright © 2020 Gulhan et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.identifier.doi10.3855/jidc.12650
dc.identifier.endpage1454
dc.identifier.issn2036-6590
dc.identifier.issue12
dc.identifier.pmid33378289
dc.identifier.scopus2-s2.0-85099082672
dc.identifier.startpage1448
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13044
dc.identifier.volume14
dc.identifier.wosWOS:000605192900015
dc.language.isoen
dc.publisherJournal of Infection in Developing Countries
dc.relation.ispartofJournal of Infection in Developing Countries
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBlastocystis
dc.subjectHemodialysis patients
dc.subjectMolecular characterization
dc.subjectST6
dc.subjectSubtype
dc.subjectAdult
dc.subjectAged
dc.subjectBlastocystis Infections
dc.subjectCross-Sectional Studies
dc.subjectFemale
dc.subjectGenetic Variation
dc.subjectHumans
dc.subjectKidney Failure, Chronic
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPhylogeny
dc.subjectPrevalence
dc.subjectRenal Dialysis
dc.subjectTurkey
dc.subjectlugol
dc.subjectmetronidazole
dc.subjectRNA 16S
dc.subjecttap water
dc.subjectabdominal pain
dc.subjectArticle
dc.subjectbacterium isolation
dc.subjectbloating
dc.subjectbody weight loss
dc.subjectconstipation
dc.subjectcontrolled study
dc.titleSubtype distribution and molecular characterization of Blastocystis from hemodialysis patients in Turkey
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus11
rdl.citation.wos11
rdl.departmentDepartment of Medical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey . drbarisgulhan@gmail.com. | Department of Medical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey . mervegazi@yahoo.com.tr. | Department of Medical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey . draytekin65@hotmail.com.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)